136 related articles for article (PubMed ID: 8983932)
1. A comparative bioavailability study to estimate the influence of an antacid on droxicam pharmacokinetics.
Maya MT; Pais JP; Ruas Da Silva J; Morais JA
Eur J Drug Metab Pharmacokinet; 1995; 20(4):275-9. PubMed ID: 8983932
[TBL] [Abstract][Full Text] [Related]
2. The effect of antacid and ranitidine on droxicam pharmacokinetics.
Bartlett A; Costa A; Martínez L; Roser R; Sagarra R; Sánchez J
J Clin Pharmacol; 1992 Dec; 32(12):1115-9. PubMed ID: 1487550
[TBL] [Abstract][Full Text] [Related]
3. The influence of gastric emptying on droxicam pharmacokinetics.
Sánchez J; Martínez L; García-Barbal J; Roser R; Bartlett A; Sagarra R
J Clin Pharmacol; 1989 Aug; 29(8):739-45. PubMed ID: 2778095
[TBL] [Abstract][Full Text] [Related]
4. Cross-over study of the bioavailability of a new NSAID (droxicam) versus piroxicam in healthy volunteers following single and multiple dose administration.
Bartlett A; Costa A; Martinez L; Roser R; Sagarra R; Sanchez J
Eur J Drug Metab Pharmacokinet; 1992; 17(3):195-9. PubMed ID: 1490488
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic profile of droxicam.
Martínez L; Sánchez J
Eur J Rheumatol Inflamm; 1991; 11(4):10-4. PubMed ID: 1365484
[TBL] [Abstract][Full Text] [Related]
6. Comparative study of the multiple dose pharmacokinetics and the tolerance of a new NSAID (droxicam) versus piroxicam in healthy volunteers.
Martínez L; Sánchez J; Roser R; García-Barbal J; Bartlett A; Estruch J; Sagarra R; Puig S; Costa A
Methods Find Exp Clin Pharmacol; 1988 Nov; 10(11):729-37. PubMed ID: 3221746
[TBL] [Abstract][Full Text] [Related]
7. Single and multiple dose pharmacokinetics of a new NSAID (droxicam) in healthy volunteers.
Martinez L; Sanchez J; Roser R; Garcia-Barbal J; Sagarra R; Bartlett A
Eur J Drug Metab Pharmacokinet; 1989; 14(4):303-7. PubMed ID: 2633925
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of tenidap sodium administered with food or antacid in healthy volunteers.
Coates PE; Mesure R
Br J Clin Pharmacol; 1995; 39 Suppl 1(Suppl 1):17S-19S. PubMed ID: 7547087
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of droxicam in rat and dog.
Esteve A; Martínez L; Roser R; Sagarra R
Methods Find Exp Clin Pharmacol; 1986 Jul; 8(7):423-9. PubMed ID: 3762266
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the influence of antacids and H2 antagonists on the absorption of moxifloxacin after oral administration of a 400mg dose to healthy volunteers.
Stass H; Böttcher MF; Ochmann K
Clin Pharmacokinet; 2001; 40 Suppl 1():39-48. PubMed ID: 11352441
[TBL] [Abstract][Full Text] [Related]
11. Plasma tenoxicam concentrations after single and multiple oral doses.
Crevoisier C; Heizmann P; Forgo I; Dubach UC
Eur J Drug Metab Pharmacokinet; 1989; 14(1):23-7. PubMed ID: 2788089
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of oxicam nonsteroidal anti-inflammatory agents.
Olkkola KT; Brunetto AV; Mattila MJ
Clin Pharmacokinet; 1994 Feb; 26(2):107-20. PubMed ID: 8162655
[TBL] [Abstract][Full Text] [Related]
13. Reduced oral itraconazole bioavailability by antacid suspension.
Lohitnavy M; Lohitnavy O; Thangkeattiyanon O; Srichai W
J Clin Pharm Ther; 2005 Jun; 30(3):201-6. PubMed ID: 15896236
[TBL] [Abstract][Full Text] [Related]
14. Reduced tetracycline bioavailability caused by magnesium aluminum silicate in liquid formulations of bismuth subsalicylate.
Healy DP; Dansereau RJ; Dunn AB; Clendening CE; Mounts AW; Deepe GS
Ann Pharmacother; 1997 Dec; 31(12):1460-4. PubMed ID: 9416381
[TBL] [Abstract][Full Text] [Related]
15. The effect of food and an antacid on the bioavailability of dexketoprofen trometamol.
McEwen J; De Luca M; Casini A; Gich I; Barbanoj MJ; Tost D; Artigas R; Mauleón D
J Clin Pharmacol; 1998 Dec; 38(S1):41S-45S. PubMed ID: 9882081
[TBL] [Abstract][Full Text] [Related]
16. Influence of the antacid Maalox and the H2-antagonist cimetidine on the pharmacokinetics of cerivastatin.
Mück W; Ritter W; Dietrich H; Frey R; Kuhlmann J
Int J Clin Pharmacol Ther; 1997 Jun; 35(6):261-4. PubMed ID: 9208343
[TBL] [Abstract][Full Text] [Related]
17. The effect of concomitantly administered antacids on the bioavailability of lornoxicam, a novel highly potent NSAID.
Dittrich P; Radhofer-Welte S; Magometschnigg D; Kukovetz WR; Mayerhofer S; Ferber HP
Drugs Exp Clin Res; 1990; 16(2):57-62. PubMed ID: 2401187
[TBL] [Abstract][Full Text] [Related]
18. Relative bioavailability of two oral formulations of piroxicam 20 mg: a single-dose, randomized-sequence, open-label, two-period crossover comparison in healthy Mexican adult volunteers.
Palma-Aguirre JA; Lopez-Gamboa M; Cariño L; Burke-Fraga V; González-de la Parra M
Clin Ther; 2010 Feb; 32(2):357-64. PubMed ID: 20206793
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and bioavailability of percutaneous ibuprofen.
Kleinbloesem CH; Ouwerkerk M; Spitznagel W; Wilkinson FE; Kaiser RR
Arzneimittelforschung; 1995 Oct; 45(10):1117-21. PubMed ID: 8595072
[TBL] [Abstract][Full Text] [Related]
20. The effects of food and of antacid on the single oral dose pharmacokinetics of tenoxicam.
Francis RJ; Dixon JS; Lowe JR; Harris PA
Eur J Drug Metab Pharmacokinet; 1985; 10(4):309-14. PubMed ID: 3879481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
